Cystic fibrosis. Cystic fibrosis, unspecified
Conditions
Interventions
Intervention 1: Intervention group: In the group receiving physiotherapy with floater (intervention), in addition to 3 sessions of physiotherapy, 3 sessions of floater will be performed between mornin
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to No maximum
Inclusion criteria
Inclusion criteria: Cystic fibrosis patients who have been diagnosed based on clinical symptoms and sweat test and have referred to the clinic or office as an outpatient Entry age is above 5 years The percentage of oxygen saturation based on pulse oximetry should be greater than or equal to 90% at room temperature Be clinically stable Able to perform the spirometry maneuver and have a minimum FEV1 greater than or equal to 30% based on the normal population based on age, gender and height Informed consent has been obtained from the patients
Exclusion criteria
Exclusion criteria: Have evidence of severe complications of lung disease including severe hemoptysis or pneumothorax within the last 2 months Have an acute upper respiratory disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Forced expiratory volume1 (FEV1). Timepoint: At the beginning of the study and 4 weeks after the intervention. Method of measurement: CHESTGRAPH HI-105 spirometer device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Forced vital capacity (FVC). Timepoint: At the beginning of the study and 4 weeks after the intervention. Method of measurement: CHESTGRAPH HI-105 spirometer device.;Forced expiratory flow 25–75 (FEF25-75%). Timepoint: At the beginning of the study and 4 weeks after the intervention. Method of measurement: CHESTGRAPH HI-105 spirometer device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeedeh Talebi
Mashhad University of Medical Sciences
Outcome results
None listed